Vivekananda Yoga program may improve patients' mental health
the ONA take:
According to a study published in the journal Integrative Cancer Therapies, researchers at the University of Texas MD Anderson Cancer Center in Houston, Texas, have found that a novel couple-based Vivekananda Yoga program appears to be safe, feasible, acceptable, and subjectively useful for patients with lung cancer and their caregivers.
For the single-arm feasibility trial, researchers enrolled 9 dyads of patients with lung cancer undergoing radiotherapy and their caregivers. All participants completed a 15-session Vivekananda Yoga program that focused on the interconnectedness of the dyad.
Results showed that 95.5% of participants subjectively rated the program as very useful. Researchers found that the program improved patients' mental health and resulted in a significant decrease in caregivers' sleep disturbances.
The authors conclude that their findings support further study of this intervention in more patients with lung cancer and their caregivers.
A novel couple-based Vivekananda Yoga program appears to be safe, feasible, acceptable, and subjectively useful for patients with lung cancer.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|